Table 4.
Dose (g/kg) | ALT (U/L) | AST (U/L) | TC (mmol/L) | TG (mmol/L) | TP (g/L) | ALB (g/L) | GLU (mmol/L) | BUN (mmol/L) | Cr (μmol/L) |
---|---|---|---|---|---|---|---|---|---|
Male | |||||||||
4 | 63.10 ± 18.63 | 104.51 ± 11.16 | 2.10 ± 0.26 | 1.03 ± 0.31 | 71.69 ± 4.96 | 35.83 ± 3.25 | 5.23 ± 0.53 | 7.21 ± 0.86 | 53.03 ± 4.65 |
2 | 64.14 ± 13.16 | 107.46 ± 6.80 | 2.09 ± 0.26 | 1.01 ± 0.21 | 71.82 ± 3.58 | 36.33 ± 1.82 | 5.34 ± 0.62 | 6.82 ± 0.77 | 54.26 ± 3.74 |
1 | 53.54 ± 16.30 | 99.78 ± 10.90 | 1.98 ± 0.36 | 1.39 ± 0.45 | 68.07 ± 4.58 | 37.14 ± 2.42 | 5.45 ± 0.53 | 7.37 ± 1.35 | 56.39 ± 6.26 |
Control | 58.18 ± 15.35 | 100.76 ± 8.42 | 2.07 ± 0.42 | 1.02 ± 0.41 | 69.75 ± 6.72 | 37.28 ± 2.83 | 5.85 ± 1.01 | 6.69 ± 1.11 | 53.78 ± 3.56 |
Female | |||||||||
4 | 58.97 ± 18.14 | 109.34 ± 8.17 | 2.09 ± 0.24 | 1.12 ± 0.25 | 71.95 ± 5.49 | 35.75 ± 2.76 | 5.15 ± 0.65 | 7.24 ± 1.06 | 56.69 ± 3.89 |
2 | 52.80 ± 8.68 | 104.66 ± 5.66 | 2.14 ± 0.43 | 1.02 ± 0.23 | 72.47 ± 4.97 | 36.58 ± 2.56 | 5.75 ± 0.76 | 6.71 ± 1.12 | 54.16 ± 3.87 |
1 | 42.99 ± 13.78 | 101.81 ± 10.00 | 2.10 ± 0.16 | 1.17 ± 0.30 | 71.60 ± 3.33 | 37.43 ± 3.18 | 5.22 ± 0.69 | 6.94 ± 1.21 | 58.09 ± 9.95 |
Control | 46.43 ± 10.56 | 102.20 ± 7.76 | 2.07 ± 0.13 | 1.09 ± 0.21 | 71.26 ± 3.39 | 37.76 ± 4.32 | 5.35 ± 0.40 | 6.90 ± 1.39 | 54.51 ± 5.29 |
Note: values represent mean ± standard deviation (n = 10). ALT, alanine transaminase; AST, aspartate transaminase; TC, total cholesterol; TG, triglyceride; TP, total protein; ALB, albumin; GLU, glucose; BUN, blood urea nitrogen; CR, creatinine. Values of the treatment groups did not differ statistically from the control according to one-way ANOVA at p < 0.05.